Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: An interobserver agreement study

Hitoshi Tsuda, Masayuki Yoshida, Futoshi Akiyama, Yasuyo Ohi, Keiichi Kinowaki, Nobue Kumaki, Yuzuru Kondo, Akihisa Saito, Eiichi Sasaki, Rieko Nishimura, Satoshi Fujii, Keiichi Homma, Rie Horii, Yuya Murata, Makiko Itami, Sabine Kajita, Hiroyuki Kato, Masafumi Kurosumi, Takashi Sakatani, Shigeki ShimizuKouhei Taniguchi, Sadafumi Tamiya, Harumi Nakamura, Chizuko Kanbayashi, Tadahiko Shien, Hiroji Iwata

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: An interobserver agreement study'. Together they form a unique fingerprint.

Medicine & Life Sciences